TWD 109.5
(-4.37%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 3.1 Billion TWD | 1.15% |
2022 | 3.07 Billion TWD | 27.13% |
2021 | 2.41 Billion TWD | 13.57% |
2020 | 2.12 Billion TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 3.16 Billion TWD | 2.04% |
2024 Q2 | 3.16 Billion TWD | -0.16% |
2023 Q1 | 3.05 Billion TWD | -0.65% |
2023 FY | 3.1 Billion TWD | 1.15% |
2023 Q4 | 3.1 Billion TWD | 1.9% |
2023 Q3 | 3.04 Billion TWD | -1.32% |
2023 Q2 | 3.08 Billion TWD | 1.26% |
2022 Q4 | 3.07 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | -7.079% |
Level Biotechnology Inc. | 822.67 Million TWD | -277.581% |
Sagittarius Life Science Corp | 664.72 Million TWD | -367.3% |
NeoCore Technology Co., Ltd. | 548.74 Million TWD | -466.062% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 20.228% |
GlycoNex Incorporation | 1.55 Billion TWD | -100.04% |
VBI | 452.1 Million TWD | -587.069% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | -164.105% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -314.958% |
Visgeneer Inc. | 397.17 Million TWD | -682.085% |
Mycenax Biotech Inc. | 3.77 Billion TWD | 17.615% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -43.872% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -251.746% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 49.016% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -4122.862% |
Enimmune corporation | 604.82 Million TWD | -413.577% |
TaiRx, Inc. | 833.74 Million TWD | -272.566% |
CHO Pharma, Inc. | 3.08 Billion TWD | -0.655% |
EirGenix Inc. | 11.16 Billion TWD | 72.173% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -441.972% |
Sunny Pharmtech Inc. | 1.71 Billion TWD | -81.402% |
Lin BioScience, Inc. | 3.59 Billion TWD | 13.637% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -195.698% |
Feng Chi Biotech Corp. | 301.03 Million TWD | -931.868% |
Bio Preventive Medicine Corp. | 264.65 Million TWD | -1073.69% |
Lukas Biomedical Inc. | 441.19 Million TWD | -604.061% |
RBC Bioscience Corporation | 753.79 Million TWD | -312.085% |
BiOptic Inc. | 613.77 Million TWD | -406.092% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | -74.639% |
Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -167.846% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -381.702% |
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -2325.869% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -720.974% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -173.958% |
Neith Corporation | 192.15 Million TWD | -1516.552% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1999.756% |
NaviFUS Corp. | 490.53 Million TWD | -533.238% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -153.424% |
Sinew Pharma Inc. | 1.36 Billion TWD | -127.836% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -487.031% |
Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -167.461% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -87.544% |
AP Biosciences Inc | 890.75 Million TWD | -248.721% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 63.573% |
3D Global Biotech Inc. | 324.14 Million TWD | -858.282% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | -132.915% |
Intech Biopharm Corporation | 2.71 Billion TWD | -14.577% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 79.782% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -657.146% |
TWi Biotechnology, Inc. | 396.85 Million TWD | -682.725% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -49.633% |
TCI GENE Inc. | 1.16 Billion TWD | -166.416% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -954.465% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | -127.843% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -229.835% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -344.735% |
PharmaEngine, Inc. | 3.95 Billion TWD | 21.439% |
Savior Lifetec Corporation | 3.82 Billion TWD | 18.741% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -152.574% |
OBI Pharma, Inc. | 5.6 Billion TWD | 44.57% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | -192.489% |
Acepodia, Inc. | 6.81 Billion TWD | 54.444% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 18.823% |